Should Australia introduce a National chlamydia testing program? Evaluation of a randomised controlled trial

澳大利亚应该引入国家衣原体检测计划吗？

• 批准号: nhmrc : 1056803
• 负责人: A/Pr James Ward
• 金额: $ 34.57万
• 依托单位: The University of Melbourne
• 依托单位国家: 澳大利亚
• 项目类别: Partnerships
• 财政年份: 2013
• 资助国家: 澳大利亚
• 起止时间: 2013-01-01 至 2018-12-31
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/australia-introduce-national-controlled-trial/454582
• 关键词: Should; Australia; introduce; National; chlamydia

Chlamydia is a very common sexually transmissible infection that can lead to infertility in women. About 4% of young adults have it, yet most are unaware they have it. Chlamydia is easy to diagnose and treat, but it is not known whether annual testing can reduce its spread. Over1 million tests are conducted each year in general practice, costing the government $30 million. This evaluation of a well-established trial of chlamydia testing in young adults will resolve the debate of whether annual testing works and is a good use of money.

衣原体是一种非常常见的性传播感染，可导致妇女不孕。大约4%的年轻人患有衣原体，但大多数人并不知道他们患有衣原体。衣原体很容易诊断和治疗，但每年检测是否能减少其传播尚不清楚。每年在一般情况下进行100多万次测试，花费政府3000万美元。这项对年轻人衣原体检测的成熟试验的评估将解决年度检测是否有效以及是否善用资金的争论。